Breast and Cervical Cancer Stigma in Rwanda
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorDana-Farber Cancer Institute
About this trial
This study aims to assess breast and cervical cancer stigma and pilot a multi-modal intervention to mitigate stigma among patients, caregivers, and community health workers in Rwanda. The elements include resilience training (patient), support group (caregivers), or exposure to survivors by video and in-person (patient, caregivers, and community health workers), and educational curriculum (community health workers).
Eligibility criteria
Qualifiers
None
Disqualifiers
Patients with pathologically confirmed breast or cervical cancer
Patients receiving treatment at BCCOE during the study period
Age 18 and over
Ability to provide informed consent
Trial design
Treatments tested in this trial
- Behavioral: RISE Intervention
- Behavioral: CHW Educational Intervention
Treatment groups
1,116 Participants
are divided into 2 treatment groupsSponsors and collaborators
Dana-Farber Cancer Institute
Lead sponsor
Dana-Farber/Harvard Cancer Center (DF/HCC) Boston, MA
Collaborator
American Association for Cancer Research
Collaborator
Breast Cancer Research Foundation
Collaborator
Source ClinicalTrials.gov